Submission Details
| 510(k) Number | K251207 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 18, 2025 |
| Decision Date | January 07, 2026 |
| Days to Decision | 264 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K251207 is an FDA 510(k) clearance for the Sangria? Thrombectomy System, a Peripheral Mechanical Thrombectomy With Aspiration (Class II — Special Controls, product code QEW), submitted by Avantec Vascular Corporation (Sunnyvale, US). The FDA issued a Cleared decision on January 7, 2026, 264 days after receiving the submission on April 18, 2025. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.5150.
| 510(k) Number | K251207 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 18, 2025 |
| Decision Date | January 07, 2026 |
| Days to Decision | 264 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | QEW — Peripheral Mechanical Thrombectomy With Aspiration |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.5150 |
| Definition | To Mechanically Disrupt Thrombus And/or Debris Prior To Removal From The Peripheral Vasculature Through Aspiration. |